China
Case Report
A Case of Advanced Pulmonary Adenocarcinoma Harboring HER-2 Amplification Treated with Afatinib
Author(s): Yan Lu, Jiahui Lan, Ling Bi and Ling XuYan Lu, Jiahui Lan, Ling Bi and Ling Xu
HER-2 amplification is a rare mutation and potential target in the treatment of pulmonary adenocarcinoma (AC). Clinical efficacy of HER-2 targeted agent has been reported for AC with HER-2 exon 20 insertions; however it remains unknown for those with HER-2 amplification. Here we report a case of advanced AC harboring HER-2 amplification treated with afatinib, and objective response and symptom improvement were observed.
.. Read More»
Journal of Bioprocessing & Biotechniques received 3351 citations as per Google Scholar report